Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 9, 2007

TGen Licenses Data Mining Software from Active Motif

  • Translational Genomics Research Institute (TGen) licensed Active Motif’s data mining software. It will use AKS2, or almaKnowledgeServer™, to interrogate genomic-profiling data, such as high-throughput siRNA screening.

    "AKS2 will help us integrate prior knowledge located in the literature in a rapid and efficient manner,” says Jeff Kiefer, head of the knowledge mining lab in TGen's pharmaceutical genomics division. “We will use AKS2 as an integral part of the knowledge mining activities that support the pharmacogenomic-based research activities within TGen.”



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »